Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Trigeminal Neuralgia (Tic Douloureux) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Trigeminal Neuralgia (Central Nervous System) pipeline landscape. Trigeminal neuralgia is a chronic pain condition that affects the ... Read More
-
Spinal Muscular Atrophy (SMA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Spinal Muscular Atrophy (SMA) (Central Nervous System) pipeline landscape. Spinal muscular atrophy (SMA) is a ... Read More
-
Liver Cirrhosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Liver Cirrhosis (Gastrointestinal) pipeline landscape. Cirrhosis is scarring of the liver caused by many forms of liver diseases and ... Read More
-
Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Diarrhea (Gastrointestinal) pipeline landscape. Diarrhea is a contagious gastrointestinal infection occurring mostly due to unhygienic conditions. Diarrhea may be related to ... Read More
-
Smallpox Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Smallpox (Infectious Disease) pipeline landscape. Smallpox is an acute contagious infection caused by the Variola virus. Symptoms include fever, malaise, headache, ... Read More
-
Attention Deficit Hyperactivity Disorder (ADHD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... (ADHD) - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System) pipeline landscape. Attention deficit hyperactivity ... Read More
-
Sedation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Sedation (Central Nervous System) pipeline landscape.Sedation is the depression of irritability or agitation. Symptoms include talk slowly and may slur their ... Read More
-
N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Sulphamidase or SGSH or EC 3.10.1.1) - N-sulphoglucosamine sulphohydrolase is an enzyme encoded by the SGSH gene. This enzyme is involved in the lysosomal degradation of heparan sulfate. Mutations in this gene are associated with ... Read More
-
Human Papillomavirus Minor Capsid Protein L2 (L2) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... minor capsid component and lacks the capacity to form VLPs. This protein plays a role in capsid stabilization through interaction with the major capsid protein L1. It also plays a role through its interaction with ... Read More
-
Human Cytomegalovirus Envelope Glycoprotein B (gB) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... molecules. Out of which approximately 11 molecules are developed by Companies. The latest report Human Cytomegalovirus Envelope Glycoprotein B - Drugs In Development, 2022, outlays comprehensive information on the Human Cytomegalovirus Envelope Glycoprotein B (gB) ... Read More
-
Birch Pollen Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Birch Pollen Allergy (Immunology) pipeline landscape. Birch pollen allergy is a reaction which occurs soon after exposure ... Read More
-
Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase or LTA4H or EC 3.3.2.6) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... the recently published report 'Leukotriene A 4 Hydrolase - Drugs In Development, 2022'; Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase or LTA4H or EC 3.3.2.6) pipeline Target constitutes close to 6 ... Read More
-
Serine Protein Kinase ATM (Ataxia Telangiectasia Mutated or ATM or EC 2.7.11.1) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Mutated or ATM or EC 2.7.11.1) - Serine Protein Kinase ATM is a serine/threonine protein kinase. It activates checkpoint signaling upon double strand breaks (DSBs), apoptosis and genotoxic stresses such as ionizing ultraviolet A light ... Read More
-
T-Cell Lymphomas Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020-2030
... non-Hodgkin lymphomas (NHL), representing less than 15% of NHL in the US. The most important clinical distinction is made in separating primary cutaneous TCLs (CTCL), which affect primarily the skin, from peripheral TCLs (PTCL), which ... Read More
-
Opioid-Induced Constipation (OIC) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Opioid-Induced Constipation (OIC) (Toxicology) pipeline landscape. Opioids are effective pain relievers, but often have the side effect ... Read More
-
Gonorrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Gonorrhea (Infectious Disease) pipeline landscape. Gonorrhea is a sexually transmitted disease (STD) caused by Neisseria gonorrhoeae bacterium. It can infect both ... Read More
-
Atrial Fibrillation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Atrial Fibrillation (Cardiovascular) pipeline landscape. Atrial fibrillation is an irregular and often rapid heart rate that commonly causes poor ... Read More
-
Insulin Resistance Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Insulin Resistance (Metabolic Disorders) pipeline landscape. Insulin resistance (IR) is a condition in which the body's cells become resistant ... Read More
-
Diabetic Peripheral Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Diabetic Peripheral Neuropathy (Metabolic Disorders) pipeline landscape. Diabetic neuropathy is nerve damage caused by diabetes. The type ... Read More
-
Erectile Dysfunction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Erectile Dysfunction (Male Health) pipeline landscape. Erectile dysfunction, or ED, is the inability of a man to have an ... Read More
-
Crigler-Najjar Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Crigler-Najjar Syndrome (Genetic Disorders) pipeline landscape. Crigler-Najjar syndrome is a severe condition characterized by high levels of a toxic ... Read More
-
Sandhoff Disease (Jatzkewitz-Pilz Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Sandhoff Disease (Jatzkewitz-Pilz Syndrome) (Genetic Disorders) pipeline landscape. Sandhoff disease is an inherited lipid storage ... Read More
-
Contrast Induced Nephropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Contrast Induced Nephropathy (Genito Urinary System And Sex Hormones) pipeline landscape. Contrast-induced nephropathy (CIN) is defined as ... Read More
-
Osteomyelitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Osteomyelitis (Infectious Disease) pipeline landscape. Osteomyelitis is an infection in a bone. Infections can reach a bone by traveling through the ... Read More
-
Batten Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Batten Disease (Central Nervous System) pipeline landscape. Batten disease, a rare genetic disorder, belongs to a group of progressive ... Read More
Research Assistance
